The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

FLORIDA: President-elect Donald Trump said on Thursday he has selected Robert F. Kennedy Jr, an environmental activist who ...

WASHINGTON (Reuters) - U.S. President-elect Donald Trump is expected to select Robert F. Kennedy Jr. to lead the Department ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

Donald Trump’s nomination of vaccine-skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services is sending shockwaves throughout the broader pharma industry, beyond [vaccine ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

As the controlling shareholder of Novo Nordisk, a leading Danish pharmaceutical company, the takeover emerges amidst rising ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...